home > epc

European Pharmaceutical Contractor


European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.


For further information please contact:

Jonathan Smith

Aimee-Rose O'Driscoll

We're also on Twitter! Follow us @EPCmagazine

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.

View the digital version of EPC


Featured in this issue
Legal & Regulatory
Identification of Medicinal Products

Hidden Benefits

In mid-2016, the requirements of the Identification of Medicinal Products guidance will come into full effect. Due to their complexity, adhering to these new standards will be no mean feat – Wim Cypers at ArisGlobal tells us how to get the most our of compliance.

Therapeutic Innovation

Therapeutic Thought

Although the method has become a focal point of many oncology pipelines, there is a prevailing resistance to utilising immunotherapy. Cedric Francois and Pascal Deschatelets of Apellis Pharmaceuticals state its case for transforming autoimmunity management.


  The introduction
Editor’s Letter

With compliance deadlines looming, Graham Hughes reflects on the various regulatory updates featured in this issue.

Edited by
Dr Graham Hughes,
Consultant in
Published quarterly in
March, June,
September and December

Banner of ESMO.EPC on Samedan
Banner of Bioclinica.EPE on Samedan
Industry Events

Analytical Method Development, Validation and Transfer

15-16 September 2015, Maritim proArte Hotel Berlin, Germany

Informa Life Sciences' 5th Annual Analytical Method Development, Validation and Transfer is a dedicated forum focusing on industry case studies, regulatory agency feedback and interactive formats to enable increased speed and efficiency.
More info >>

News and Press Releases

Aptar Pharma Twister® Chosen for Asthma Therapy

Louveciennes, France – April 2, 2015 – Aptar Pharma, a global solution provider of innovative and proven aerosol, injection and spray delivery systems for biotech, healthcare and pharma products has partnered with Shanghai Sine Promod Pharmaceutical Co., Ltd. to develop and launch its new Budesonide DPI (Dry Powder Inhaler), which uses Aptar Pharma’s novel, user-friendly and cost-effective Twister® Dry Powder Inhaler.
More info >>

air transport logo


White Papers

Faster, Better, Cheaper: Lean as a Driving Force Behind Pharmaceutical Companies’ Growth

TBM Consulting Group

The pharmaceutical industry faces countless challenges: patent expirations, weak product development pipelines, downward pricing pressure and an increasingly burdensome regulatory environment. The most important question for companies is now “How can we position ourselves optimally to be successful in the long term?” Some pharmaceutical companies used the economic downturn in 2009 to embrace measures in the fields of cost reduction and efficiency increases, which can be implemented at short notice. The continuous and consistent implementation of sustainable measures that guarantee stability and form the basis for future growth was not necessarily paramount within this.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement